Sponsor Dossier
Key Pharmaceuticals
Sponsor Dossier for Key Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: Blistex
- Brand: CHARCOCAPS
- Brand: Charcotabs
- Brand: CYVENTINE
- Brand: DIAREZE
- Brand: DOZILE
- Brand: EARCLEAR
- Brand: GASBUSTERS
- Device (sponsor): Acupressure wristband
- Device (sponsor): Clinical chemistry hormone IVDs
- Device (sponsor): Compress, hot/cold pack, reusable
- Device (sponsor): Earwax softening otic solution
- Device (sponsor): Shield, nipple, reusable
- Device (sponsor): Lice comb kit
- Device (sponsor): Lice comb kit
- Device (sponsor): Lice comb kit
- Device (sponsor): Comb, lice
- Device (sponsor): Lice treatment solution
- Device (sponsor): Irrigation kit, <specify>
- Device (sponsor): Stimulator, <specify>
- Device (sponsor): Irrigation kit, ear
About
Key Pharmaceuticals is an Australian Private Company with ABN 21001215130, registered in NSW and currently active.
Portfolio
Key Pharmaceuticals has 21 brands on the ARTG, of which 3 are indexable and 2 carry a Product Information document. 1 brand is PBS-listed, 0 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include Blistex, CHARCOCAPS, Charcotabs, CYVENTINE, DIAREZE, DOZILE, EARCLEAR, GASBUSTERS, Hamilton, MEDIJEL, MINTEC, NeutraLice Natural Oils.
Therapeutic focus
— Gastroenterology: 6 brands — Complementary Medicine: 5 brands — Dermatology: 3 brands — Pain Management: 3 brands — Psychiatry: 2 brands — Reproductive Health: 1 brand — Other: 1 brand
PBS footprint
1 brand is PBS-listed, with the latest PBS schedule date 2026-10-01.